Investigating treatment outcomes for patients with cardiogenic shock
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK - an International, Observational Registry
This study looks at how different treatments for cardiogenic shock work for patients to see which ones are most effective and what side effects they might have.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg) |
| Trial ID | NCT03313687 on ClinicalTrials.gov |
What this trial studies
This international observational registry aims to assess the clinical outcomes of patients experiencing cardiogenic shock. The study focuses on various treatment strategies, including interventional therapies and mechanical circulatory support, while monitoring the drug therapies and devices used in these patients. By documenting the practices at participating sites, the study seeks to provide insights into the effectiveness and side effects of current treatment approaches for cardiogenic shock.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with cardiogenic shock who are being treated at a tertiary care hospital.
Not a fit: Patients under the age of 17 will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for patients suffering from cardiogenic shock.
How similar studies have performed: Other studies focusing on treatment outcomes in cardiogenic shock have shown promise, indicating that this approach is relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with cardiogenic shock treated at a tertiary care hospital. Exclusion Criteria: * Age ≤17 years.
Where this trial is running
Hamburg
- University Heart Center — Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Dirk Westermann, MD — Uhz
- Study coordinator: Benedikt Schrage, MD
- Email: b.schrage@uke.de
- Phone: +49 40 7410 18135
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.